- 19057
Our training program is 30 months long during which the fellow is totally engaged within the training activities, journal club, assignments, didactics, and clinical rotation. The program is collaboratively developed by CCHE 57357 and DF/BC. The curriculum is mainly adopted from the American Academy of Pediatric Hematology/Oncology guidelines and the Royal College of Physicians and Surgeons of Canada Guidelines for Pediatric Hematology/Oncology.
The principal features of the program include the following:
Over two years of clinical training, fellows get the opportunity to rotate through five services: hematologic malignancy, solid tumor, stem cell transplantation, ambulatory hematology, and neuro-oncology. Uniquely, the fellows receive training in radio diagnosis; clinical pathology; surgical pathology; palliative care and critical care. The program offers a high degree of "hands-on" clinical responsibility; where the fellows get to follow 20-25 oncology patients, 4-6 stem cell transplant patients on average, functioning as their primary caregiver. The system ensures that fellows are introduced to a wide range of disease states.
All fellows are expected to receive baseline research training. Based on their interest, fellows can receive clinical research or translational research training. Clinical research training covers biostatistics, clinical trials, clinical epidemiology, ethics, experimental design, and/or health services research. On the other hand, translational research covers a training in a basic laboratory field as well as, utilizing patient specimens to inform new attempts at discovery at the bench.
